Covid-19 Komplikasyonu Olarak Protrombotik ve Tromboembolik Olaylar
References
Yılmaz H, Topçuoğlu P. COVID-19 ile İlişkili Koagülopati ve Yönetimi. LLM Dergi 2020;4(4):55-60. 10.5578/llm.20219901.
Ünüvar A. COVID-19 ve Koagülopati. İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2020, Cilt 3, Ek sayı 1. doi:10.26650/JARH52020-S1-0007.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Feb 15;395:497-506.doi: 10.1016/ S0140-6736(20)30183-5.
Seo J-W, Kim D-Y, Yun N, Kim D-M. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022, 10, 1556. https://doi.org/10.3390/microorganisms10081556.
Cannegieter SC, Klok FA. COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance. Res Pract Thromb Haemost 2020 April 20. doi:10.1002/rth2.12350.
Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292
Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590.
van Doremalen N., Bushmaker T., Morris D.H. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031.
Memikoğlu O, Genç V. COVID-19. Ankara Üniversitesi Tıp Fakültesi. Ankara Üniversitesi Basımevi. 2021. Genişletilmiş 2. Baskı. Karabak B, Bayar MK. Bölüm 22. COVID-19 ve Tromboembolik Olaylar.157-166.
Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148.
Lippi G., Favaloro E.J. D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Thromb Haemost. 2020; 120(5):876-878. doi: 10.1055/s-0040-1709650.
Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
Gao Y., Li T., Han M. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020; 92(7):791-796. doi: 10.1002/jmv.25770.
Lippi G., Salvagno G.L., Ippolito L., Franchini M., Favaloro E.J. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis. 2010;21:459–463.
Zimmermann F.M., De Bruyne B., Pijls N.H. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015;170:619–626.e2
Thygesen K., Alpert J.S., Jaffe A.S. Fourth Universal Definition of Myocardial Infarction (2018) J Am Coll Cardiol. 2018;72:2231–2264.
Ekim M, Ekim H. Pandemi döneminde venöz sistem hastalıklarının tedavisi. Euroasia Journal of Mathematics, Engineering, Natural & Medical Sciences International Indexed and Refereed.2022;(9)20:65-73. doi: 10.38065/euroasiaorg.931.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the Cardiovascular System. Nat Rev Cardiol2020;17(5):259-260.
Bellosta R, Luzzani L, Natalini G, Pegorer MA, Attisani L, Cossu LG, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg.2020;72(6):1864-1872.
Üzümcügil AO, Demirkiran ND, Öner SK, Akkurt A, Alkan Çeviker S. Limb ischemia associated with Covid-19 and its treatment with above-kneeamputation. Int J Low Extrem Wounds. 2021:15347346211063257.
Makhoul K, Shukha Y, Hanna LA, Nitecki S, Leiderman M, Hayek T, et al. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19. Int J Infect Dis. 2021;106:401-404.
Topcu AC, Ozturk-Altunyurt G, Akman D, Batirel A, Demirhan R. Acute limb ischemia in hospitalized Covid-19 patients. Ann Vasc Surg. 2021;74:88-94.
Kahraman AN, Vural A. COVID-19 Hastalarında Akut İskemik İnme Sıklığında Artış. Acıbadem Univ. Sağlık Bilim. Derg. 2022; 13 (1): 90-95. https://doi.org/10.31067/acusaglik.997072.
Topçuoğlu MA, Arsava EM, Özdemir AÖ. COVID-19 Pandemisinde akut iskemik inme tedavisi: Uzman görüşü. Türk Beyin Damar Hastalıkları Dergisi 2020; 26(1): doi: 10.5505/tbdhd.2020.00000.
Levi M, Toh CH,Thachil J,Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24–33.
Crackower MA, Sarao R, Oudit GY. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828.
COVID-19 (SARS-CoV-2 Enfeksiyonu) antisitokin-Antiinflamatuar Tedaviler, Koagülopati Yönetimi. Bilimsel Danışma Kurulu Çalışması.T:C: Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. T.C. Sağlık Bakanlığı. 07 Kasım 2020, Ankara.
Ünüvar A. COVID-19 ve Koagülopati. İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2020, Cilt 3, Ek sayı 1. doi:10.26650/JARH52020-S1-0007.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Feb 15;395:497-506.doi: 10.1016/ S0140-6736(20)30183-5.
Seo J-W, Kim D-Y, Yun N, Kim D-M. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022, 10, 1556. https://doi.org/10.3390/microorganisms10081556.
Cannegieter SC, Klok FA. COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance. Res Pract Thromb Haemost 2020 April 20. doi:10.1002/rth2.12350.
Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292
Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590.
van Doremalen N., Bushmaker T., Morris D.H. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031.
Memikoğlu O, Genç V. COVID-19. Ankara Üniversitesi Tıp Fakültesi. Ankara Üniversitesi Basımevi. 2021. Genişletilmiş 2. Baskı. Karabak B, Bayar MK. Bölüm 22. COVID-19 ve Tromboembolik Olaylar.157-166.
Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148.
Lippi G., Favaloro E.J. D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Thromb Haemost. 2020; 120(5):876-878. doi: 10.1055/s-0040-1709650.
Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
Gao Y., Li T., Han M. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020; 92(7):791-796. doi: 10.1002/jmv.25770.
Lippi G., Salvagno G.L., Ippolito L., Franchini M., Favaloro E.J. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis. 2010;21:459–463.
Zimmermann F.M., De Bruyne B., Pijls N.H. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015;170:619–626.e2
Thygesen K., Alpert J.S., Jaffe A.S. Fourth Universal Definition of Myocardial Infarction (2018) J Am Coll Cardiol. 2018;72:2231–2264.
Ekim M, Ekim H. Pandemi döneminde venöz sistem hastalıklarının tedavisi. Euroasia Journal of Mathematics, Engineering, Natural & Medical Sciences International Indexed and Refereed.2022;(9)20:65-73. doi: 10.38065/euroasiaorg.931.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the Cardiovascular System. Nat Rev Cardiol2020;17(5):259-260.
Bellosta R, Luzzani L, Natalini G, Pegorer MA, Attisani L, Cossu LG, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg.2020;72(6):1864-1872.
Üzümcügil AO, Demirkiran ND, Öner SK, Akkurt A, Alkan Çeviker S. Limb ischemia associated with Covid-19 and its treatment with above-kneeamputation. Int J Low Extrem Wounds. 2021:15347346211063257.
Makhoul K, Shukha Y, Hanna LA, Nitecki S, Leiderman M, Hayek T, et al. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19. Int J Infect Dis. 2021;106:401-404.
Topcu AC, Ozturk-Altunyurt G, Akman D, Batirel A, Demirhan R. Acute limb ischemia in hospitalized Covid-19 patients. Ann Vasc Surg. 2021;74:88-94.
Kahraman AN, Vural A. COVID-19 Hastalarında Akut İskemik İnme Sıklığında Artış. Acıbadem Univ. Sağlık Bilim. Derg. 2022; 13 (1): 90-95. https://doi.org/10.31067/acusaglik.997072.
Topçuoğlu MA, Arsava EM, Özdemir AÖ. COVID-19 Pandemisinde akut iskemik inme tedavisi: Uzman görüşü. Türk Beyin Damar Hastalıkları Dergisi 2020; 26(1): doi: 10.5505/tbdhd.2020.00000.
Levi M, Toh CH,Thachil J,Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24–33.
Crackower MA, Sarao R, Oudit GY. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828.
COVID-19 (SARS-CoV-2 Enfeksiyonu) antisitokin-Antiinflamatuar Tedaviler, Koagülopati Yönetimi. Bilimsel Danışma Kurulu Çalışması.T:C: Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. T.C. Sağlık Bakanlığı. 07 Kasım 2020, Ankara.
Volume
Pages
107-116
Published
May 3, 2024
Copyright (c) 2024 Academician Publishing Book Portal
